Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolomics for the early detection of cisplatin-induced nephrotoxicity
Takeshi Ezaki, Shin Nishiumi, Takeshi Azuma, et al.
Toxicology Research (2017) Vol. 6, Iss. 6, pp. 843-853
Open Access | Times Cited: 23

Showing 23 citing articles:

Integration of GC–MS and LC–MS for untargeted metabolomics profiling
Özge Cansın Zeki, Cemil Can Eylem, Tuba Reçber, et al.
Journal of Pharmaceutical and Biomedical Analysis (2020) Vol. 190, pp. 113509-113509
Closed Access | Times Cited: 242
Identification of key metabolites during cisplatin-induced acute kidney injury using an HPLC-TOF/MS-based non-targeted urine and kidney metabolomics approach in rats
Xiaoyu Qu, Huan Gao, Jingmeng Sun, et al.
Toxicology (2020) Vol. 431, pp. 152366-152366
Closed Access | Times Cited: 50
Toxicometabolomics: Small Molecules to Answer Big Toxicological Questions
Ana Margarida Araújo, Félix Carvalho, Paula Guedes de Pinho, et al.
Metabolites (2021) Vol. 11, Iss. 10, pp. 692-692
Open Access | Times Cited: 38
Metabolomics for the identification of early biomarkers of nephrotoxicity in a mouse model of cisplatin-induced acute kidney injury
Yong Jin Lim, Nicholas C. Tonial, Emily D. Hartjes, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114787-114787
Open Access | Times Cited: 15
<p>Metabolomics: a promising diagnostic and therapeutic implement for breast cancer</p>
Zhanghan Chen, Zehuan Li, Haoran Li, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 6797-6811
Open Access | Times Cited: 35
UHPLC-MS-based untargeted metabolomic strategy to reveal the metabolic differences between cisplatin first- and second-generation apoptotic bodies from HK-2 cells
Samuel Bernardo‐Bermejo, María Castro‐Puyana, Elena Sánchez‐López, et al.
Microchemical Journal (2024) Vol. 200, pp. 110406-110406
Open Access | Times Cited: 3
Integrated Metabolomics and Network Pharmacology Strategy-Driven Active Traditional Chinese Medicine Ingredients Discovery for the Alleviation of Cisplatin Nephrotoxicity
Lei Xu, Yuxin Zhang, Pei Zhang, et al.
Chemical Research in Toxicology (2019) Vol. 32, Iss. 12, pp. 2411-2421
Closed Access | Times Cited: 32
A luminescent on–off probe based calix[4]arene linked through triazole with ruthenium(ii) polypyridine complexes to sense copper(ii) and sulfide ions
Mohanraj Ramachandran, Sambandam Anandan, Muthupandian Ashokkumar
New Journal of Chemistry (2019) Vol. 43, Iss. 25, pp. 9832-9842
Closed Access | Times Cited: 31
Analysis of cantharidin-induced nephrotoxicity in HK-2 cells using untargeted metabolomics and an integrative network pharmacology analysis
Tianmu He, Jingxian Liu, Xiaoning Wang, et al.
Food and Chemical Toxicology (2020) Vol. 146, pp. 111845-111845
Closed Access | Times Cited: 27
Preclinical studies on metal based anticancer drugs as enabled by integrated metallomics and metabolomics
Luis Galvez, Mate Rusz, Michaela Schwaiger-Haber, et al.
Metallomics (2019) Vol. 11, Iss. 10, pp. 1716-1728
Open Access | Times Cited: 25
Metabolomic identification of predictive and early biomarkers of cisplatin‐induced acute kidney injury in adult head and neck cancer patients
Yong Jin Lim, Steven G. Xiu, M. Sara Kuruvilla, et al.
British Journal of Clinical Pharmacology (2023) Vol. 90, Iss. 8, pp. 1790-1803
Open Access | Times Cited: 7
Broad range lipidomics and metabolomics coupled with 16S rRNA sequencing to reveal the mechanisms of Huangkui Capsule against cisplatin-induced nephrotoxicity
Jian‐Cheng Liao, Jie Xiang, Wan‐Yu Gui, et al.
Journal of Ethnopharmacology (2024) Vol. 340, pp. 119197-119197
Closed Access | Times Cited: 2
Syntheses, structures and anti-tumor activity of four organotin(iv) dicarboxylates based on (1,3,4-thiadiazole-2,5-diyldithio)diacetic acid
Fei-Fei Yan, Chunlin Ma, Qian‐Li Li, et al.
New Journal of Chemistry (2018) Vol. 42, Iss. 14, pp. 11601-11609
Closed Access | Times Cited: 20
All-trans retinoic acid prevents cisplatin-induced nephrotoxicity in rats
Cem Yücel, Elçin Erdoğan Yücel, Fatma Demet Arslan, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2019) Vol. 392, Iss. 2, pp. 159-164
Closed Access | Times Cited: 19
Multi-Organ NMR Metabolomics to Assess In Vivo Overall Metabolic Impact of Cisplatin in Mice
Tatiana J. Carneiro, Rita Araújo, Martin Vojtek, et al.
Metabolites (2019) Vol. 9, Iss. 11, pp. 279-279
Open Access | Times Cited: 17
Novel Insights into Mice Multi-Organ Metabolism upon Exposure to a Potential Anticancer Pd(II)-Agent
Tatiana J. Carneiro, Rita Araújo, Martin Vojtek, et al.
Metabolites (2021) Vol. 11, Iss. 2, pp. 114-114
Open Access | Times Cited: 10
Spatial evaluation of long-term metabolic changes induced by cisplatin nephrotoxicity
Mikail Sahin, Judith Martha Neumann, Bjoern Riefke, et al.
Toxicology Letters (2020) Vol. 334, pp. 36-43
Closed Access | Times Cited: 4
Metabolomic Profiles in Patients with Cervical Cancer Undergoing Cisplatin and Radiation Therapy
Seo-Yeon Choi, Suin Kim, Ji‐Young Jeon, et al.
Biomolecules & Therapeutics (2024) Vol. 32, Iss. 3, pp. 379-389
Open Access
The Current State of Proteomics and Metabolomics for Inner Ear Health and Disease
Motahare Khorrami, Christopher J. Pastras, Paul A. Haynes, et al.
Proteomes (2024) Vol. 12, Iss. 2, pp. 17-17
Open Access
Rational analysis of data from LC-MS/MS: new insights in acylcarnitines as biomarkers for brain disorders or neurotoxicity
Li Chen, Ruiqin Zhu, Yaxing Ma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Biomarkers Detection for Toxicity Testing Using Metabolomics
David J. Borts
Elsevier eBooks (2019), pp. 1111-1124
Closed Access | Times Cited: 1
Identification of Novel and Early Biomarkers for Cisplatin-induced Nephrotoxicity and the Nephroprotective Role of Cimetidine using a Pharmacometabolomic-based Approach Coupled with In Vitro Toxicodynamic Modeling and Simulation
Hardik Mody, Sreenath Nair, Adrian Rump, et al.
Journal of Pharmaceutical Sciences (2023) Vol. 113, Iss. 1, pp. 268-277
Open Access
Conventional and Emerging Renal Biomarkers
Sue Ford
Elsevier eBooks (2019), pp. 267-275
Closed Access
Page 1

Scroll to top